Skip to main content
. 2015 May;7(5):881–889. doi: 10.3978/j.issn.2072-1439.2015.04.41

Table 1. The demographic and clinical characteristics of subjects.

Variables Initial mono-therapy group (N=32,682) Initial combination group (N=4,926) Statistics P
Age (years) 59.17±11.69 58.45±11.33 t=4.05 <0.0001
Gender
  Men 16,759 (51.28) 2,775 (56.33) χ2=43.86 <0.0001
  Women 15,923 (48.72) 2,151 (43.67)
BMI 24.44±3.22 24.88±3.64 t=8.78 <0.0001
Baseline blood pressure
  SBP 146.12±12.67 148.08±14.08 t=9.97 <0.0001
  DBP 89.49±8.57 90.17±9.58 t=5.11 <0.0001
History of illness
  Myocardial infarction 145 (0.44) 29 (0.59) χ2=1.96 0.1620
  Angina 567 (1.73) 118 (2.40) χ2=10.45 0.0012
  Congestive heart failure 102 (0.31) 21 (0.43) χ2=1.71 0.1906
  Kidney disease 255 (0.78) 47 (0.95) χ2=1.63 0.2024
Risk factor
  Smoking 5,993 (18.34) 1,068 (21.78) χ2=31.38 <0.0001
  Total cholesterol >5.72 mmol/L 1,147 (4.02) 212 (4.79) χ2=7.75 0.005
  Family history of early onset cardiovascular disease 1,857 (6.51) 286 (6.45) χ2=0.12 0.8812
  Diabetes 3,732 (12.96) 582 (13.06) χ2=0.66 0.417
Target organ damage
  Left ventricular hypertrophy 418 (1.28) 80 (1.63) χ2=3.90 0.0486
  Proteinuria or mildly increased plasma creatinine 383 (1.18) 83 (1.69) χ2=9.21 0.0024
  Carotid ultrasound or X-ray-confirmed atherosclerotic plaque 1,967 (6.06) 308 (6.30) χ2=0.41 0.5081
  Retinal artery stenosis 643 (2.08) 93 (2.00) χ2=0.14 0.7189

SBP, systolic blood pressure; DBP, diastolic blood pressure.